Bringing the fundamentals into focus…
Back to Vaxart, Inc.
How Vaxart, Inc. stacks up
VXRT · against 91 other Healthcare companies of similar size
Valuation
96/ 100
Near the top of its peers.
Ranked #7 of 92 · scores higher than 92% of peers
Bars: peers in each 10-point band of the valuation score13 peers with a valuation score of 90–100, including VXRT · Click a bar to see the companies
Why valuation scores 96?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield, EBITDA yield and free cash flow yield, which are stronger than most Healthcare peers.
- more operating profit (EBITDA) for the company's total value: stronger than 99% of peers. EBITDA yield: 99.9% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 99% of peers. Free cash flow yield: 34.2% vs peer median 0.0%
- higher earnings for the price paid: stronger than 100% of peers. Earnings yield: 42.5% vs peer median 1.5%
Metric by metric
Position: dot = VXRT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VXRT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 76 reported | 42.5% | -14.6% | 96% | 30% | |
| EBITDA yieldHigher is better · 100 reported | 99.9% | -3.5% | 94% | 50% | |
| Free cash flow yieldHigher is better · 70 reported | 34.2% | -15.0% | 100% | 20% | |
| Book yieldHigher is better · 80 reported | 97.5% | 70.9% | 56% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around VXRT| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 212M AUD (≈$140M) | 99 | 61 | |
| 6 | 4.5B TWD (≈$138M) | 98 | 62 | |
| 7 | 277M MYR (≈$61M) | 96 | 67 | |
| 7 | 97M USD | 96 | 63 | |
| 9 | 5.3B TWD (≈$165M) | 93 | 69 | |
| 10 | 2.91T IDR (≈$180M) | 92 | 50 | |
| 11 | 178.5B KRW (≈$129M) | 91 | 76 | |
| 12 | 1.2B NOK (≈$115M) | 90 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score